Clinical Trial

Swing-Mesh™ Study (SMS).

Study acronym: SMS
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This multicenter, prospective observational study aims to assess the safety and efficacy of the Swing-Mesh™ implant (THT BioScience™, distributed by B. Braun™, France) for laparoscopic-endoscopic inguinal hernia repair using TAPP or TEP techniques. Swing-Mesh™ is a lightweight, macroporous, three-dimensional mesh designed to conform anatomically to the myopectineal orifice without requiring fixation. Eligible adult patients undergoing elective repair will receive the implant. The primary endpoint is hernia recurrence within 6 months. Secondary endpoints include postoperative pain, groin discomfort, and early and late complications. The study will provide clinical evidence regarding the non-inferiority of this spatial, fixation-free mesh compared to standard devices in minimally invasive hernia surgery.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-01; most recent amendment 2025-12-04.
Status change: Recruiting → Active, Not Recruiting 2025-12-04
Status change: Not Yet Recruiting → Recruiting 2025-04-07
Trial Details
NCT Number NCT06915155
Lead Sponsor Swissmed Hospital
Conditions Inguinal Hernia
Enrollment 300 participants
Start Date 2025-04-07
Primary Completion 2025-08-30 (estimated)
Study Completion 2026-08-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-05